Literature DB >> 670085

Globomycin, a new peptide antibiotic with spheroplast-forming activity. III. Structural determination of globomycin.

M Nakajima, M Inukai, T Haneishi, A Terahara, M Arai, T Kinoshita, C Tamura.   

Abstract

The structure of globomycin has been determined by mass, PMR and CMR spectra and by chemical degradation. Globomycin is a new cyclic peptide antibiotic composed of L-serine, L-allo-threonine, glycine, N-methylleucine, L-allo-isoleucine and 3-hydroxy-2-methylnonaic acid. Among these components, L-allo-threonine, L-allo-isoleucine and 3-hydroxy-2-methylnonaic acid are novel components from natural products. A newly developed mass analysis has been introduced for determining the diastereoisomers of allo-threonine.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 670085     DOI: 10.7164/antibiotics.31.426

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  10 in total

1.  Existence of the bound form of prolipoprotein in Escherichia coli B cells treated with globomycin.

Authors:  M Inukai; M Takeuchi; K Shimizu; M Arai
Journal:  J Bacteriol       Date:  1979-12       Impact factor: 3.490

2.  The 34-kilodalton membrane immunogen of Treponema pallidum is a lipoprotein.

Authors:  M A Swancutt; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

3.  Characterization of CmaA, an adenylation-thiolation didomain enzyme involved in the biosynthesis of coronatine.

Authors:  Robin Couch; Sarah E O'Connor; Heather Seidle; Christopher T Walsh; Ronald Parry
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

4.  Globomycin sensitivity of Escherichia coli and Salmonella typhimurium: effects of mutations affecting structures of murein lipoprotein.

Authors:  J S Lai; W M Philbrick; S Hayashi; M Inukai; M Arai; Y Hirota; H C Wu
Journal:  J Bacteriol       Date:  1981-01       Impact factor: 3.490

5.  Preferential selection of deletion mutations of the outer membrane lipoprotein gene of Escherichia coli by globomycin.

Authors:  L J Zwiebel; M Inukai; K Nakamura; M Inouye
Journal:  J Bacteriol       Date:  1981-01       Impact factor: 3.490

6.  Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.

Authors:  Kelly L Johnston; Bo Wu; Ana Guimarães; Louise Ford; Barton E Slatko; Mark J Taylor
Journal:  Parasit Vectors       Date:  2010-10-14       Impact factor: 3.876

7.  Effect of Novel Compound LX519290, a Derivative of l-allo Threonine, on Antioxidant Potential in Vitro and in Vivo.

Authors:  Kun Chun; Md Badrul Alam; Hyeong-U Son; Sang-Han Lee
Journal:  Int J Mol Sci       Date:  2016-09-01       Impact factor: 5.923

Review 8.  Bacterial Signal Peptides- Navigating the Journey of Proteins.

Authors:  Sharbani Kaushik; Haoze He; Ross E Dalbey
Journal:  Front Physiol       Date:  2022-07-26       Impact factor: 4.755

9.  Analysis of lipoprotein transport depletion in Vibrio cholerae using CRISPRi.

Authors:  Florence Caro; Nicole M Place; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-01       Impact factor: 11.205

Review 10.  Mode of action of lipoprotein modification enzymes-Novel antibacterial targets.

Authors:  Simon Legood; Ivo G Boneca; Nienke Buddelmeijer
Journal:  Mol Microbiol       Date:  2020-10-12       Impact factor: 3.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.